Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...

Precision gene editing can be achieved by base editing, nucleotide editing, or editing of small or large gene fragments. The specific mechanisms include various DNA repair pathways. Many precision ...

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is one of the most promising tools of contemporary genetic engineering. Previously identified as a defense mechanism against ...

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

The startup aims to create a platform for treating extremely rare genetic mutations, armed with CRISPR advances and new regulatory pathways.

There’s nothing new about genetic engineering. By cross-breeding plants and animals, our Stone Age ancestors realised they could boost the amount of food they produced. Modern genetics has enabled ...

After raising $213 million in 2023—one of the year’s largest private biotech rounds—Tome Biosciences is making cuts. “Despite our clear scientific progress, investor sentiment has shifted dramatically ...

Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.

It has been seven years since Chinese biophysicist He Jiankui made an announcement that shocked the world's scientists. He had made the world's first gene-edited babies. Through rewriting DNA in twin ...